Preface |
|
xvii | |
1 Introduction |
|
1 | (18) |
|
|
5 | (2) |
|
|
7 | (1) |
|
1.3 Types of bonds in materials |
|
|
7 | (4) |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (4) |
|
|
11 | (1) |
|
|
12 | (2) |
|
|
14 | (1) |
|
|
14 | (1) |
|
1.5 Impact of biomaterials |
|
|
15 | (1) |
|
1.6 Future of biomaterials |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
18 | (1) |
2 Basic properties of materials |
|
19 | (29) |
|
2.1 Mechanical properties |
|
|
20 | (15) |
|
|
21 | (5) |
|
2.1.2 Compressive testing |
|
|
26 | (1) |
|
|
27 | (1) |
|
2.1.4 Bend or flexural tests |
|
|
27 | (1) |
|
2.1.5 Viscoelastic behavior |
|
|
28 | (2) |
|
2.1.6 Ductile and brittle fracture |
|
|
30 | (2) |
|
2.1.7 Stress concentration |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
34 | (1) |
|
2.2 Electrochemical properties |
|
|
35 | (8) |
|
|
35 | (2) |
|
|
37 | (6) |
|
|
43 | (2) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
46 | (2) |
3 Biological systems |
|
48 | (26) |
|
3.1 The biological environment |
|
|
48 | (3) |
|
3.2 Genetic regulation and control systems |
|
|
51 | (1) |
|
|
51 | (2) |
|
3.3.1 Membranes are phospholipid layers |
|
|
52 | (1) |
|
3.4 Cytoskeleton and motility |
|
|
53 | (2) |
|
3.5 Cell to cell communication pathways |
|
|
55 | (2) |
|
|
57 | (5) |
|
|
57 | (2) |
|
|
59 | (2) |
|
3.6.3 Adherens and desmosomes |
|
|
61 | (1) |
|
3.7 Cell signaling pathways |
|
|
62 | (6) |
|
3.7.1 Receptors as signaling sensors |
|
|
63 | (1) |
|
|
64 | (2) |
|
3.7.3 Second messengers and their activation/deactivation |
|
|
66 | (2) |
|
3.8 Biological testing techniques |
|
|
68 | (4) |
|
3.8.1 Probe and labeling technologies |
|
|
68 | (1) |
|
3.8.2 Examination of gene expression |
|
|
69 | (1) |
|
3.8.3 The plasma membrane |
|
|
69 | (1) |
|
3.8.4 Cytoskeleton and motility |
|
|
70 | (1) |
|
3.8.5 Communication between cells |
|
|
71 | (1) |
|
3.8.6 Mapping intracellular signaling |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
4 Characterization of biomaterials |
|
74 | (39) |
|
|
75 | (5) |
|
4.2 Infrared spectroscopy |
|
|
80 | (7) |
|
4.2.1 Attenuated total reflection (ATR) |
|
|
83 | (2) |
|
4.2.2 Specular reflectance |
|
|
85 | (1) |
|
4.2.3 Infrared reflection absorption spectroscopy (IRRAS) |
|
|
85 | (1) |
|
4.2.4 Diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) |
|
|
85 | (2) |
|
4.3 X-ray photoelectron spectroscopy |
|
|
87 | (4) |
|
4.4 Secondary ion mass spectrometry |
|
|
91 | (3) |
|
4.5 Atomic force microscopy |
|
|
94 | (4) |
|
4.6 Scanning electron microscopy |
|
|
98 | (2) |
|
4.7 Transmission electron microscopy |
|
|
100 | (3) |
|
4.8 X-ray diffraction (XRD) |
|
|
103 | (3) |
|
|
106 | (4) |
|
4.9.1 High performance liquid chromatography (HPLC) |
|
|
106 | (2) |
|
4.9.2 Gel permeation chromatography (GPC) |
|
|
108 | (2) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (2) |
5 Metals: structure and properties |
|
113 | (21) |
|
5.1 Titanium and its alloys |
|
|
114 | (5) |
|
5.1.1 Classification of Ti and its alloys based on crystallographic forms |
|
|
116 | (3) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (4) |
|
5.2.1 Martensitic stainless steels |
|
|
120 | (1) |
|
5.2.2 Ferritic stainless steels |
|
|
120 | (1) |
|
5.2.3 Austenitic stainless steels |
|
|
120 | (2) |
|
5.2.4 Duplex stainless steels |
|
|
122 | (1) |
|
5.2.5 Recent developments in stainless steel alloys |
|
|
122 | (1) |
|
5.3 Cobalt-chromium alloys |
|
|
123 | (3) |
|
|
123 | (2) |
|
|
125 | (1) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
126 | (2) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
132 | (2) |
6 Polymers |
|
134 | (31) |
|
6.1 Molecular structure of polymers |
|
|
135 | (6) |
|
|
139 | (2) |
|
6.2 Types of polymerization |
|
|
141 | (1) |
|
6.3 Physical states of polymers |
|
|
142 | (4) |
|
|
142 | (2) |
|
|
144 | (2) |
|
6.4 Common polymeric biomaterials |
|
|
146 | (9) |
|
|
146 | (1) |
|
6.4.2 Polymethylmethacrylate (PMMA) |
|
|
147 | (3) |
|
6.4.3 Polylactic acid (PLA) and polyglycolic acid (PGA) |
|
|
150 | (2) |
|
6.4.4 Polycaprolactone (PCL) |
|
|
152 | (1) |
|
6.4.5 Other biodegradable polymers |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
154 | (1) |
|
|
155 | (6) |
|
6.5.1 Synthesis of hydrogels |
|
|
159 | (1) |
|
6.5.2 Properties of hydrogels |
|
|
160 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
163 | (1) |
|
|
163 | (1) |
|
|
163 | (2) |
7 Ceramics |
|
165 | (33) |
|
|
166 | (1) |
|
|
167 | (2) |
|
7.2.1 Classification based on form |
|
|
167 | (1) |
|
7.2.2 Classification based on composition |
|
|
168 | (1) |
|
7.2.3 Classification based on reactivity |
|
|
169 | (1) |
|
|
169 | (20) |
|
|
170 | (4) |
|
|
174 | (3) |
|
|
177 | (2) |
|
|
179 | (1) |
|
7.3.5 Calcium phosphates (CaP) |
|
|
180 | (3) |
|
7.3.6 Hydroxyapatite (HA) |
|
|
183 | (3) |
|
7.3.7 Tricalcium phosphate (TCP) |
|
|
186 | (1) |
|
7.3.8 Calcium sulfate (CaSO4•H2O) |
|
|
187 | (1) |
|
|
188 | (1) |
|
|
189 | (6) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (1) |
|
|
196 | (2) |
8 Natural biomaterials |
|
198 | (35) |
|
|
199 | (5) |
|
|
204 | (3) |
|
|
207 | (3) |
|
|
210 | (3) |
|
|
213 | (4) |
|
|
217 | (6) |
|
|
223 | (3) |
|
|
226 | (2) |
|
|
228 | (3) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
232 | (1) |
9 Surface modification |
|
233 | (49) |
|
|
234 | (3) |
|
9.2 Plasma glow discharge treatments |
|
|
237 | (6) |
|
9.2.1 Direct current glow discharge |
|
|
239 | (1) |
|
9.2.2 Alternating current glow discharge |
|
|
240 | (1) |
|
9.2.3 Capacitively coupled radiofrequency glow discharge |
|
|
241 | (1) |
|
9.2.4 Inductively coupled radiofrequency glow discharge |
|
|
242 | (1) |
|
|
243 | (8) |
|
9.4 Physical vapor deposition (PVD) |
|
|
251 | (10) |
|
9.4.1 Evaporative deposition |
|
|
252 | (1) |
|
9.4.2 Pulsed laser deposition |
|
|
253 | (1) |
|
|
254 | (7) |
|
9.5 Chemical vapor deposition (CVD) |
|
|
261 | (3) |
|
|
264 | (2) |
|
9.7 Self-assembled monolayer (SAM) |
|
|
266 | (8) |
|
9.7.1 Patterning of self-assembled monolayers |
|
|
271 | (3) |
|
9.8 Layer-by-layer (LbL) assembly |
|
|
274 | (5) |
|
9.8.1 Different layer-by-layer (LbL) assembly techniques |
|
|
277 | (2) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
280 | (1) |
|
|
280 | (2) |
10 Sterilization of biomedical implants |
|
282 | (13) |
|
|
282 | (1) |
|
|
283 | (2) |
|
10.3 Ethylene oxide sterilization |
|
|
285 | (2) |
|
10.4 Gamma radiation sterilization |
|
|
287 | (2) |
|
10.5 Other sterilization methods |
|
|
289 | (2) |
|
10.5.1 Dry heat sterilization |
|
|
289 | (1) |
|
10.5.2 Formaldehyde and glutaraldehyde treatments |
|
|
290 | (1) |
|
10.5.3 Phenolic and hypochloride solution treatments |
|
|
290 | (1) |
|
10.5.4 Ultraviolet (UV) radiation |
|
|
290 | (1) |
|
10.5.5 Electron beam sterilization |
|
|
291 | (1) |
|
10.6 Recently developed methods |
|
|
291 | (1) |
|
10.6.1 Low temperature gas plasma treatment |
|
|
291 | (1) |
|
10.6.2 Gaseous chlorine dioxide treatment |
|
|
292 | (1) |
|
|
292 | (1) |
|
|
293 | (1) |
|
|
293 | (1) |
|
|
294 | (1) |
11 Cell-biomaterial interactions |
|
295 | (26) |
|
11.1 The extracellular environment |
|
|
297 | (12) |
|
11.2 Extracellular matrix mimics |
|
|
309 | (1) |
|
11.3 Cell interactions with non-cellular substrates |
|
|
309 | (5) |
|
11.4 Biocompatibility testing and techniques |
|
|
314 | (5) |
|
11.4.1 Immunostaining techniques for studying cell-ECM interactions |
|
|
316 | (1) |
|
11.4.2 Profiling a cell line for its ECM binding characteristics |
|
|
317 | (1) |
|
11.4.3 Immunoprecipitation and Western blotting |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
320 | (1) |
12 Drug delivery systems |
|
321 | (20) |
|
12.1 Diffusion controlled drug delivery systems |
|
|
323 | (2) |
|
12.1.1 Membrane controlled reservoir systems |
|
|
323 | (1) |
|
12.1.2 Monolithic matrix systems |
|
|
324 | (1) |
|
12.2 Water penetration controlled drug delivery systems |
|
|
325 | (3) |
|
12.2.1 Osmotic pressure controlled drug delivery systems |
|
|
326 | (1) |
|
12.2.2 Swelling controlled drug delivery system |
|
|
327 | (1) |
|
12.3 Chemically controlled drug delivery systems |
|
|
328 | (3) |
|
12.3.1 Polymer-drug dispersion systems |
|
|
328 | (1) |
|
12.3.2 Polymer-drug conjugate systems |
|
|
329 | (2) |
|
12.4 Responsive drug delivery systems |
|
|
331 | (4) |
|
12.4.1 Temperature-responsive drug delivery systems |
|
|
331 | (1) |
|
12.4.2 pH-responsive drug delivery systems |
|
|
332 | (1) |
|
12.4.3 Solvent-responsive drug delivery systems |
|
|
333 | (1) |
|
12.4.4 Ultrasound-responsive drug delivery systems |
|
|
333 | (1) |
|
12.4.5 Electrically responsive drug delivery systems |
|
|
334 | (1) |
|
12.4.6 Magnetic-sensitive drug delivery systems |
|
|
334 | (1) |
|
|
335 | (2) |
|
12.5.1 Polymeric microparticles |
|
|
335 | (1) |
|
12.5.2 Polymeric micelles |
|
|
336 | (1) |
|
|
336 | (1) |
|
|
337 | (2) |
|
|
339 | (1) |
|
|
339 | (1) |
|
|
340 | (1) |
13 Tissue engineering |
|
341 | (34) |
|
13.1 Tissue engineering approaches |
|
|
342 | (2) |
|
13.1.1 Assessment of medical need |
|
|
342 | (1) |
|
13.1.2 Selecting a tissue engineering strategy |
|
|
343 | (1) |
|
|
344 | (5) |
|
|
345 | (2) |
|
13.2.2 Biopreservation of cells |
|
|
347 | (2) |
|
|
349 | (1) |
|
13.4 Fabrication techniques for polymeric scaffolds |
|
|
350 | (4) |
|
13.4.1 Solvent casting and particulate leaching |
|
|
350 | (1) |
|
|
350 | (1) |
|
13.4.3 Solid free form fabrication (SFFF) |
|
|
351 | (3) |
|
13.5 Fabrication of natural polymer scaffolds |
|
|
354 | (3) |
|
13.6 Fabrication techniques for ceramic scaffolds |
|
|
357 | (1) |
|
13.6.1 Template sponge coating |
|
|
357 | (1) |
|
13.6.2 Non-sintering techniques |
|
|
357 | (1) |
|
13.7 Assessment of scaffold architecture |
|
|
358 | (3) |
|
13.8 Cell seeded scaffolds |
|
|
361 | (6) |
|
13.8.1 Cell culture bioreactors |
|
|
361 | (2) |
|
|
363 | (1) |
|
|
364 | (2) |
|
13.8.4 Mechanical modulation |
|
|
366 | (1) |
|
13.9 Assessment of cell and tissue properties |
|
|
367 | (5) |
|
13.9.1 Cellular properties |
|
|
367 | (4) |
|
|
371 | (1) |
|
13.10 Challenges in tissue engineering |
|
|
372 | (1) |
|
|
373 | (1) |
|
|
373 | (1) |
|
|
373 | (1) |
|
|
374 | (1) |
14 Clinical applications |
|
375 | (24) |
|
14.1 Cardiovascular assist devices |
|
|
376 | (2) |
|
14.2 Cardiovascular stents |
|
|
378 | (3) |
|
|
381 | (3) |
|
|
384 | (2) |
|
|
386 | (1) |
|
|
387 | (3) |
|
|
390 | (3) |
|
|
393 | (1) |
|
|
394 | (3) |
|
|
397 | (1) |
|
|
397 | (1) |
|
|
397 | (2) |
Index |
|
399 | |